Drutz D, Cline M, Levy L
J Clin Invest. 1974; 53(2):380-6.
PMID: 11344550
PMC: 301479.
DOI: 10.1172/JCI107570.
Mandel T, Cheers C
Infect Immun. 1980; 30(3):851-61.
PMID: 6785235
PMC: 551393.
DOI: 10.1128/iai.30.3.851-861.1980.
Nelson D, Nelson M, THURSTON J, Waters M, Pearson J
Clin Exp Immunol. 1971; 9(1):33-43.
PMID: 5559093
PMC: 1712991.
Turk J
Proc R Soc Med. 1970; 63(10):1053-6.
PMID: 5483516
PMC: 1811674.
Saha K, Mittal M
Clin Exp Immunol. 1970; 6(6):969-74.
PMID: 5477731
PMC: 1712813.
Contribution of modern immunological concepts to an understanding of diseases of the skin.
Turk J
Br Med J. 1970; 3(5719):363-8.
PMID: 5451586
PMC: 1701292.
DOI: 10.1136/bmj.3.5719.363.
Immunological problems in leprosy research. 1. Clinical and pathological spectrum of leprosy.
Bull World Health Organ. 1970; 43(6):879-90.
PMID: 5314019
PMC: 2427818.
Immunological aspects of leprosy with special reference to autoimmune diseases.
Wager O
Bull World Health Organ. 1969; 41(6):793-804.
PMID: 5309531
PMC: 2427576.
Immunological significance of changes in lymph nodes across the leprosy spectrum.
Turk J, Waters M
Clin Exp Immunol. 1971; 8(3):363-76.
PMID: 4930640
PMC: 1712922.
Cell-mediated immunological processes in leprosy.
Turk J
Bull World Health Organ. 1969; 41(6):779-92.
PMID: 4908550
PMC: 2427593.
DOI: 10.5935/0305-7518.19700030.
Immune responses in mice with murine leprosy.
Ptak W, Gaugas J, Rees R, Allison A
Clin Exp Immunol. 1970; 6(1):117-24.
PMID: 4906524
PMC: 1712749.
Evaluation of cell mediated immune responses in untreated cases of leprosy.
Talwar G, Krishnan A, Mehra V, Blum E, Pearson J
Clin Exp Immunol. 1972; 12(2):195-203.
PMID: 4567646
PMC: 1553575.
T and B lymphocytes in patients with lepromatous leprosy.
Mendes N, Kopersztych S, Mota N
Clin Exp Immunol. 1974; 16(1):23-9.
PMID: 4549618
PMC: 1553982.
Thymus-dependent lymphocytes of peripheral blood in leprosy patients.
Lim S, Kiszkiss D, Jacobson R, Choi Y, GOOD R
Infect Immun. 1974; 9(2):394-9.
PMID: 4544619
PMC: 414815.
DOI: 10.1128/iai.9.2.394-399.1974.
Heterologous specific antiserum for identification of human T lymphocytes.
Touraine J, Touraine F, Kiszkiss D, Choi Y, GOOD R
Clin Exp Immunol. 1974; 16(4):503-20.
PMID: 4143194
PMC: 1553996.
Experimental murine leprosy: induction of immunity and immune paralysis to Mycobacterium lepraemurium in C57BL mice.
Closs O
Infect Immun. 1975; 12(4):706-13.
PMID: 1104475
PMC: 415345.
DOI: 10.1128/iai.12.4.706-713.1975.
Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis.
Veress B, Omer A, Satir A, El Hassan A
Immunology. 1977; 33(5):605-10.
PMID: 590992
PMC: 1445510.
Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
Convit J, Aranzazu N, Pinardi M, Ulrich M
Clin Exp Immunol. 1979; 36(2):214-20.
PMID: 383331
PMC: 1537730.
Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.
Nelson D, Penrose J, Waters M, Pearson J, Nelson M
Clin Exp Immunol. 1975; 22(3):385-92.
PMID: 131666
PMC: 1538440.
